Dataset Information


Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.

ABSTRACT: Human matrix metalloproteinase-26 (MMP-26/endometase/matrilysin-2) is a putative biomarker for carcinomas of breast, prostate, and other cancers of epithelial origin. MMP-26 expression was silenced using small interfering RNA (siRNA) in the human breast cancer cell line MDA-MB-231. Immunological and proteomics approaches, including two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization time-of-flight mass spectrometry, were employed to identify differential protein expression in MMP-26 knockdown cells. A comparison of the protein expression profiles of control and MMP-26 knockdown cells revealed nine differentially regulated proteins. Five of the proteins (heat shock protein 90, glucose-regulated protein 78 (GRP78), annexin V, tropomyosin, and peroxiredoxin II) were up-regulated, while alpha-tubulin, cystatin SA-III, breast cancer metastasis suppressor 1 (BRMS1) and beta-actin were down-regulated. This decrease of BRMS1 expression is concomitant with an increase of invasion through matrix-coated membranes. These results suggest an important role for MMP-26 in the regulation of proteins involved in invasive and metastatic breast cancers.


PROVIDER: S-EPMC3069352 | BioStudies | 2011-01-01

REPOSITORIES: biostudies

Similar Datasets

1997-01-01 | S-EPMC19803 | BioStudies
1998-01-01 | S-EPMC1219442 | BioStudies
2010-01-01 | S-EPMC2801054 | BioStudies
2007-01-01 | S-EPMC1828896 | BioStudies
2001-01-01 | S-EPMC1221897 | BioStudies
2001-01-01 | S-EPMC99589 | BioStudies
2009-01-01 | S-EPMC2716959 | BioStudies
2002-01-01 | S-EPMC122942 | BioStudies
2018-01-01 | S-EPMC5940808 | BioStudies
2014-01-01 | S-EPMC4748839 | BioStudies